John Glenn insider trades: Iradimed (IRMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | IRMD | ↓ Sell | 15,000 | $97.29 | $1.5M | Direct | Dec 12, 2025 (1d) |
| Nov 10, 2025 | IRMD | ↓ Sell | 10,651 | $84.51 | $900K | Direct | Nov 12, 2025 (2d) |
| Dec 2, 2024 | IRMD | ↓ Sell | 2,500 | $54.18 | $135K | Direct | Dec 2, 2024 (0d) |
| Mar 22, 2022 | EKSO | ↓ Sell | 3,462 | $2.82 | $10K | Direct | Mar 28, 2022 (6d) |
| May 31, 2019 | EKSO | ↓ Sell | 10,292 | $1.37 | $14K | Direct | Jun 19, 2019 (19d) |
| Nov 15, 2006 | CTEC | ↓ Sell | 5,000 | $17.63 | $88K | Direct | Nov 17, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRMD insiders
Open-market trades in the last 12 months
About John Glenn's insider trades
John Glenn is CFO at Iradimed (IRMD). Since Nov 15, 2006, John has reported no open-market purchases and 6 sales worth $2.6M on SEC Form 4. In the last 12 months: 2 sales ($2.4M).
Their filings also include grants and awards (20 filings), option exercises (10 filings), shares withheld for taxes (9 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.